Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Nov;21(11):2262-2266.
doi: 10.1093/annonc/mdq215. Epub 2010 Apr 27.

Surveillance CT scans are a source of anxiety and fear of recurrence in long-term lymphoma survivors

Affiliations

Surveillance CT scans are a source of anxiety and fear of recurrence in long-term lymphoma survivors

C A Thompson et al. Ann Oncol. 2010 Nov.

Abstract

Background: We aimed to assess anxiety and the psychological impact of routine surveillance scans in long-term survivors of adult aggressive lymphoma.

Patients and methods: In this cross-sectional observational study of 70 survivors of curable adult aggressive lymphoma, we measured anxiety and the doctor-patient relationship and performed a qualitative interview (n = 30) focused on patient perception of routine follow-up imaging studies.

Results: Participants were diagnosed with aggressive lymphoma a median of 4.9 years (2.4-38.0 years) before enrollment. Thirty-seven percent of patients were found to meet criteria for clinically significant anxiety, which was not associated with years since diagnosis. In multivariate analysis, history of relapse and a worse doctor-patient relationship were independently associated with higher anxiety levels. Despite representing a largely cured population, in qualitative interviews patients reported fear of recurrence as a major concern and considerable anxiety around the time of a follow-up imaging scan.

Conclusions: Routine surveillance scans exacerbate underlying anxiety symptoms and fear of recurrence in survivors of aggressive lymphoma. Strategies to minimize follow-up imaging and to improve doctor-patient communication should be prospectively evaluated to address these clinically significant issues.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Edelman MM, Meyers FJM, Siegel D, et al. The utility of follow-up testing after curative cancer therapy. A critical review and economic analysis. J Gen Intern Med. 1997;12:318–331. - PMC - PubMed
    1. Dryver ET, Jernstrom H, Tompkins K, et al. Follow-up of patients with Hodgkin’s disease following curative treatment: the routine CT scan is of little value. Br J Cancer. 2003;89:482–486. - PMC - PubMed
    1. Xavier MF, Schuster SJ, Andreadis C, et al. Detection of relapse in diffuse large B-cell lymphoma (DLBCL) and Hodgkin’s lymphoma (HL): observations and implications for post-remission radiologic surveillance. Blood (ASH Annual Meeting Abstracts) 2006;108 2428.
    1. Foltz LM, Song KW, Connors JM. Who actually detects relapse in Hodgkin lymphoma: patient or physician? Blood (ASH Annual Meeting Abstracts) 2004;104 3124.
    1. Seam P, Juweid ME, Cheson BD. The role of FDG-PET scans in patients with lymphoma. Blood. 2007;110:3507–3516. - PubMed

Publication types

MeSH terms